Home » Stocks » ORMP » Statistics

Oramed Pharmaceuticals Inc. (ORMP)

Stock Price: $13.86 USD 0.38 (2.82%)
Updated Jun 22, 2021 4:00 PM EDT - Market closed

Total Valuation

ORMP has a market cap or net worth of $418.97 million. The enterprise value is $362.78 million.

Market Cap 418.97M
Enterprise Value 362.78M

Important Dates

The next estimated earnings date is July 7, 2021, which is a Wednesday.

Estimated Earnings Date Jul 7, 2021
Ex-Dividend Date n/a

Share Statistics

ORMP has 27.00 million shares outstanding. The number of shares has increased by 51.55% in one year.

Shares Outstanding 27.00M
Share Change (YoY) +51.55%
Share Change (QoQ) +13.72%
Owned by Insiders (%) 10.24%
Owned by Institutions (%) 10.13%
Float 27.85M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 155.11
PB Ratio 8.47
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 134.31
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.69, with a Debt / Equity ratio of 0.01.

Current Ratio 9.69
Quick Ratio 9.57
Debt / Equity 0.01
Debt / EBITDA -0.04
Debt / FCF -0.04

Financial Efficiency

Return on Equity (ROE) -47.18%
Return on Assets (ROA) -21.83%
Return on Capital (ROIC) -61.90%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.06
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a
Taxes as % of Revenue n/a

Stock Price Statistics

The stock price has increased by +232.84% in the last 52 weeks. The beta is 1.90, so ORMP's price volatility has been higher than the market average.

Beta (1Y) 1.90
52-Week Price Change +232.84%
50-Day Moving Average 12.03
200-Day Moving Average 8.91
Average Volume (30 Days) 488,922

Short Selling Information

The latest short interest is 2.48 million, so 9.19% of the outstanding shares have been sold short.

Short Interest 2.48M
Short % of Shares Out 9.19%
Short Ratio (days to cover) 6.10

Income Statement

In the last 12 months, ORMP had revenue of $2.70 million and -$15.46 million in losses. Earnings per share was -$0.63.

Revenue 2.70M
Gross Profit 2.70M
Operating Income -15.99M
Net Income -15.46M
EBITDA -14.99M
EBIT -15.02M
Earnings Per Share (EPS) -$0.63
Full Income Statement

Balance Sheet

The company has $56.79 million in cash and $608,000 in debt, giving a net cash position of $56.18 million or $2.08 per share.

Cash & Cash Equivalents 56.79M
Total Debt 608,000
Net Cash 56.18M
Net Cash Per Share $2.08
Book Value 49.44M
Book Value Per Share 1.83
Working Capital 51.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.22 million and capital expenditures -$425,000, giving a free cash flow of -$15.64 million.

Operating Cash Flow -15.22M
Capital Expenditures -425,000
Free Cash Flow -15.64M
FCF Per Share -$0.58
Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -591.85% and -572.31%.

Gross Margin 100.00%
Operating Margin -591.85%
Profit Margin -572.31%
EBITDA Margin -554.94%
EBIT Margin -556.24%
FCF Margin -579.08%

Dividends & Yields

ORMP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -3.69%
FCF Yield -3.73%
Dividend Growth (YoY) n/a
Payout Ratio n/a

Stock Splits

The last stock split was on January 23, 2013. It was a reverse split with a ratio of 1:12.

Last Split Date Jan 23, 2013
Split Type Reverse
Split Ratio 1:12